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Abstract
2 H NMR spectroscopy and freeze-fracture electron microscopy were used to compare the transmembrane domains of two
 .Class I protein receptor tyrosine kinases the EGF receptor and NeurerbB-2 regarding overall behaviour in fluid lipid
bilayer membranes. The 34-residue peptide, EGFR , was synthesised to contain the 23 amino acid hydrophobic stretchtm
 .  .Ile to Met thought to span the membrane of the human EGF receptor, plus the first 10 amino acids Arg to Thr622 644 645 654
of the cytoplasmic domain. Deuterium probes replaced selected 1H nuclei at sites corresponding to Ala , Met , and623 644
 .Val . The 38-residue peptide, Neu , was synthesised having the 21 residue hydrophobic stretch Ile to Ile650 tm 660 680
calculated to span the membrane in rat NeurerbB-2, plus residues Lys to Thr of the contiguous cytoplasmic domain.681 691
Deuterium probes replaced selected 1H nuclei at Ala , Leu , and Val . A third peptide, Neu ), was also prepared,661 667 676 tm
corresponding to the transmembrane domain of a constitutively-activating NeurerbB-2 transformant in which Val is664
replaced by Glu: it was deuterated in a manner identical to Neu . Peptides were studied by 2 H NMR spectroscopy at 1tm
 .mol% and 6 mol% in unsonicated fluid bilayers of 1-palmitoyl-2-oleoylphosphatidylcholine POPC and in POPC
containing 33 mol% cholesterol, over the range 128 to 658C. Overall motion was found to be different for each of the three
peptides under a given set of conditions. EGFR spectra were characteristic of axially symmetric motion in membranes oftm
POPC alone, and in POPCrcholesterol at 358C and above. In contrast, spectra of the transmembrane peptides, Neu andtm
Neu ), were characteristic of significantly axially asymmetric motion under all conditions studied and regardless oftm
.sample preparation method . Addition of 33% cholesterol to membranes was accompanied by spectral changes consistent
with increased formation of peptide dimersroligomers in all cases. The transformant peptide, Neu ), showed greatertm
spectral evidence of immobilisation than did the wild type - probably reflecting a greater tendency to form large oligomers.
Sequence-related details within the transmembrane domains of Class I receptor tyrosine kinases appear to exert important
control over their associations within membranes. Freeze-fracture electron microscopy of the NMR samples demonstrated
 .their liposomal nature. Peptide-related intramembranous particles IMPs were present which likely represent oligomers of
the transmembrane peptide. IMP size and distribution were similar under a given set of conditions for all three peptides,
Abbreviations: RTK, receptor tyrosine kinase; EGF, epidermal growth factor; EGFR , 34-amino-acid peptide corresponding to thetm
w x w x w xhuman EGF receptor transmembrane domain plus 10 residues of the cytoplasmic domain; d Ala d Met d Val , deuterated4 623 3 644 8 650
amino acids corresponding to the indicated positions in the human EGF receptor; Neu, rat protein also known as NeurerbB-2 or
w x w x w xNeurHER2; Neu , synthetic transmembrane 38 mer from Neu; d Ala d Leu d Val , deuterated amino acids correspondingtm 3 661 3 667 8 676
to the indicated positions in Neu; Neu ), Neu having Val replaced with Glu—an oncogenic mutation; POPC, 1-palmitoyl-2-oleoyltm tm 664
phosphatidylcholine; TFE, trifluoroethanol
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suggesting that the differences seen by NMR spectroscopy reflect structures smaller than the 2 nm resolution limit of
freeze-fracture EM and peptide relationships within its 20 nm accuracy of identifying lateral position. q 1998 Elsevier
Science B.V. All rights reserved.
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1. Introduction
The epidermal growth factor receptor also called
. c-erbB-1 in humans and NeurerbB-2 also referred
 4.to as NeurHER2 c-erbB-2 in humans are impor-
 . w xtant Class I receptor tyrosine kinases RTKs 1–7 .
They are highly homologous proteins that coexist
within the plasma membrane of a given cell and are
thought to have different, yet somewhat interdepen-
dent, signalling functions. Each possesses an external
glycosylated portion responsible for the earliest events
in recognition; a hydrophobic stretch of sufficient
length to cross the bilayer membrane once; and an
intracellular portion exhibiting phosphorylation sites,
docking sites, and protein kinase activity. Consider-
able attention has focused on these and related species
with regard to the molecular mechanism of signal
transduction.
It is now widely considered that the transmem-
brane domains of RTKs can form meaningful side-
to-side associations that are critical early events in
w xsignal transduction pathways 5–12 . The Class I
species, NeurerbB-2 and the EGF receptor, have
served as platforms for the development of innova-
tive and compelling mechanisms for such effects
w x13–21 . In these models the concept that transmem-
brane domains of Class I RTKs are capable of direct
homodimeric interaction is clearly a central one, and
one which has become increasingly validated with
the emergence of evidence that single amino acid
substitutions in the transmembrane domain of the
w x w xEGF receptor 22 as well as in NeurerbB-2 13 , can
trigger abnormal cell behaviour. Nevertheless, con-
troversy surrounds the details of the proposed mecha-
nisms—including the role of conformation, motifs,
and non-covalent bond formation. Moreover, while
receptor dimerisation is often assumed to be the
operational triggering event, workers have also sug-
gested that monomers may be active forms in the
same or related pathways and that dimerisation is in
 w x.itself not sufficient as a trigger e.g., 23–29 .
Wideline 2H NMR spectroscopy lends itself well
to studying structural aspects of such issues since the
technique utilises non-perturbing probes localised to
the molecule of interest, which can then be dispersed
as a minor component in multi-component membrane
assemblies. One can work at physiological tempera-
tures, and without the need to sonicate or to add
detergent-like molecules. The approach has benefited
wfrom extensive development by other workers 30–
x 240 . Recently, we reported H NMR experiments on
the transmembrane domain of the human EGF recep-
 .tor c-erbB-1 , demonstrating that the spectra ob-
tained could be understood in terms of previous 2H
NMR studies on model hydrophobic peptides and
ones from prokaryotic organisms, and that the results
provided a measure of homodimeric interactions be-
w xtween the transmembrane domains 41,42 .
NeurerbB-2 is a potentially interesting comparator
for the EGF receptor. The two have considerable
homology, yet NeurerbB-2 is often viewed as an
RTK that is especially sensitive to alterations within
w xthe transmembrane domain 10 : a single amino acid
alteration of Val to Glu leads to cell transforma-664
w x tion 13 it should be noted however that an analo-
gous Val “Glu substitution in the EGF receptor627
has also been recently claimed to have metabolic
w x.effects 22 . In the present work, we tested for
sequence-related aspects of transmembrane domain
behaviour that might direct the function of these two
Class I receptors.
The peptide, EGFR , corresponding to residuestm
621 to 654 of the human EGF receptor, was prepared
by solid phase synthesis. This sequence represents the
 .putative transmembrane region residues 622 to 644
and a 10-residue stretch of the cytoplasmic domain
including the Thr residue which is phosphorylated654
 .apparently as a regulatory mechanism during EGF-
w xmediated signal transduction 43 . Three different
deuterated amino acids were incorporated at topo-
graphically distinct sites within EGFR . Methyltm
groups were chosen as deuteron locations because of
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the relatively good signal-to-noise ratio afforded by
three equivalent nuclei. The same approach was taken
to NeurerbB-2. Neu was synthesised to contain thetm
21 residue hydrophobic stretch thought to span the
 .membrane Ile to Ile of rat Neu and residues660 680
Lys to Thr of the contiguous cytoplasmic do-681 691
main. Deuterium probes replaced selected 1H nuclei
at Ala , Leu , and Val . Neu ) was also661 667 676 tm
synthesised, corresponding to the transmembrane do-
main of the constitutively-activating NeurerbB-2
transformant in which Val is replaced by Glu.664
The study of transmembrane subunits of RTK’s for
insight into their mechanistic function in signalling
seems justified by the ‘two step’ model of membrane
protein biogenesis, whereby transmembrane a-helices
are thought to insert across the membrane and subse-
quently associate to form functional multi-subunit
w xcomplexes 44 . It has been generally observed that,
in folded membrane proteins, the conformation of
transmembrane segments is little altered from that
which would be predicted based on the conformation
w xand transbilayer locus of the separate entities 9 .
Moreover, numerous functional chimeric Class I re-
ceptors have now been produced in which the trans-
membrane domain is employed as a separate cassette
 w x.e.g., 45,46 . The phospholipid selected for peptide
reassembly, 1-palmitoyl-2-oleoyl phosphatidylcholine
 .POPC , reflects the monounsaturated nature, chain
length, and low phase transition temperature of com-
mon naturally-occurring species in higher animal
plasma membranes. POPC has a gelrfluid phase
w xtransition temperature of y38C 47 , and the phase
behaviour of its mixtures with cholesterol has been
w xcharacterised 48 : all samples studied in the present
work represented fluid membranes at the tempera-
tures investigated.
2. Materials and methods
1-Palmitoyl-2-oleoyl-3-sn-phosphatidylcholine
 .POPC , 1,2-3-sn-dimyristoyl phosphatidylcholine
 . DMPC and L-a-phosphatidylserine beef brain, )
. 99% were obtained from Avanti Polar Lipids Bi-
.rmingham, AL and were used without further purifi-
cation. 9-Fluorenylmethyl N-succinimidylcarbonate
 . FMOC-OSu and cholesterol were from Sigma St.
. w x .Louis, MO . Deuteromethyl L-methionine d Met ,3
w x .perdeuterated L-alanine d Ala , and deuterium-de-4
 2 .pleted water -0.5 ppm H , were from Isotec
 . w x .Miamisburg, OH . Perdeuterated L-valine d Val ,8
w x .deuteromethyl L-alanine d Ala , and deuteromethyl3
w x .L-leucine d Leu , were from Cambridge Isotope3
 .Laboratories Andover, MA .
FMOC-blocked amino acids were synthesized fol-
lowing standard procedures as described previously
w x 41 . Product purity was checked by TLC Merck,
.silica gel 60 plates against an FMOC-derivative
standard. The EGFR peptide was synthesized bytm
 .Chiron Mimotopes Clayton, Australia , and se-
quence confirmed by mass spectroscopy and amino
w xacid analysis, purity 85–95% 41 . Neu and Neu )tm tm
were also synthesised by Chiron. Initial purity was
60%. This was improved by HPLC to 80% as fol-
lows. 20 mg peptide was dissolved in 500 ml of
1,1,1,3,3,3-hexafluoro-2-propanol Aldrich, ‘99 q
.%’ and filtered through an Acrodisc CR PFTE 0.45
 .mm minispike Gelman Sciences, Ann Arbor, MI . A
50-ml volume was applied to a Waters mBondapak
NH Radial-Pak cartridge 8=100 mm, 10-mm par-2
˚ .ticle size, 125 A pore size , eluting at 2 mlrmin with
a 0.25% miny1 gradient of 0.1% TFArCHCl to3
0.1% TFArCH OH. The Neu peptides have proven3
very difficult to isolate in highly pure form. Contami-
nants of synthetic peptides were species differing
from the target sequence by one or two amino acids.
Residual impurities in each case consisted of small
amounts of a variety of peptides of similar size.
Except where noted otherwise, liposome genera-
tion was according to the following protocol. TFE
2,2,2-trifluoroethanol, 4 ml, Aldrich, NMR grade, bp
.  .77–808C was added to dry peptide 10 mg , and
appropriate amounts of dry lipid were then weighed
in and dissolved with warming to 558C to produce
mixtures in which peptide represented 6 mol% of
phospholipid. Samples were allowed to sit at this
temperature for at least 30 min after visually-apparent
complete dissolution. Solvent was then rapidly re-
moved under reduced pressure at 458C on a rotary
evaporator to leave thin films in 50-ml round bottom
flasks. These were subsequently vacuum desiccated
for 18 h at 238C under high vacuum with continuous
evacuation. Hydration was with 25 mM HEPES pH
7.1, or 30 mM HEPES with 20 mM NaCl and 5 mM
EDTA pH 7.1–7.3-both made up in deuterium-de-
pleted water. Samples were warmed to 558C, without
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vortexing during hydration to minimize production of
small vesicles.
2H NMR spectra were acquired at 76.7 MHz on a
Varian Unity 500 spectrometer using a single-tuned
Doty 5 mm solenoid probe with temperature regula-
tion to "0.1 C8. A quadrupolar echo sequence
 .‘SSECHO’ from the Varian pulse library was em-
ployed with full phase cycling and pr2 pulse length
of 5–6 ms. Pulse spacing was typically 30 ms, and
sweep width was 100 kHz.
Samples for freeze-fracture electron microscopy
were withdrawn directly from the samples prepared
for 2H NMR or were prepared in the same fashion.
Specimens were frozen from room temperature in
liquid freon, and were fractured and Pt-shadowed at
y1108C in a Balzers BAF 301 apparatus equipped
with electron beam guns. Replicas were cleaned ini-
tially in NaClO , rinsed with distilled water, and4
immersed in 1r1 acetonerethanol to remove residual
lipid.
3. Results
Amino acid sequences for the 34-mer, EGFR ,tm
and the 38-mers, Neu rNeu ), are shown in Fig.tm tm
1. In each case they comprise the putative transmem-
brane domain and 10 or 11 residues of the cytoplas-
Fig. 1. Amino acid sequence of EGFR and of Neu rNeu ).tm tm tm
The putative transmembrane domain has been underlined cyto-
.plasmic domain to the right . Deuterated amino acids are indi-
cated by bold letter symbol: perdeuterated alanine was substituted
w x .for Ala d Ala , methionine deuterated selectively in the623 4 623
w x .methyl group for Met d Met , and perdeuterated valine644 3 644
w x .for Val d Val . In Neu and Neu ) alanine deuterated650 8 650 tm tm
selectively in the methyl group was substituted for Ala661
w x .d Ala , leucine deuterated selectively in the methyl group3 661
w x .for Leu d Leu , and perdeuterated valine for Val667 3 667 676
w x .d Val . Neu ) is identical to Neu but with a Val “8 676 tm tm 664
 .Glu substitution. A biotinylated lysine residue † replaced the
extracellular Ser in the case of EGFR . This was also the621 tm
case for Neu in the samples in which only Ala was deuter-tm 661
ated.
mic domain from the parent glycoprotein. The sug-
gested transmembrane portion calculated using the
w xmethod of Rost 49 has been underlined.
Elongated amphiphiles dispersed in fluid mem-
branes tend to undergo rapid symmetric rotation about
axes perpendicular to the bilayer. For such molecules
 .containing deuterium nuclei, Eq. 1 is useful in
2  .relating H NMR spectral splittings D˝ to molecu-Q
lar orientation and motional characteristics.
3 2 2< <D˝ s e Qqrh S 3cos Q y1 1 .Q mol i8
e2Qqrh is the nuclear quadrupole coupling con-
 . w xstant 165–170 kHz for a C–D bond 30–32 , S ismol
the molecular order parameter assuming axially
.symmetric order describing orientational fluctuations
of the C–D bond relative to the bilayer normal, and
Q is the average orientation of each C–D bondi
relative to the bilayer normal. For deuterated methyl
groups, which undergo rapid rotation about the at-
taching bond axis even at temperatures well below
08C, it is convenient to consider a ‘resultant’ C–D
vector directed along the C–CD bond. This can be3
 .dealt with in Eq. 1 by considering Q to be thei
angle between the C–CD vector and the molecular3
long axis, and introducing an additional factor of
 .1r3. Due to the S term in Eq. 1 a given splittingmol
can be reduced under the conditions of the current
experiments by ‘wobble’ of the entire peptide within
the membrane, by finite conformational fluctuations
of the peptide backbone, and by side chain internal
motions. Dominant nonaxially symmetric rotation
about an axis e.g., all twofold rotational jumps, and
 4three- or higher fold jumps with unequal population
.weighting of available conformers , can cause a shift
in intensity toward the spectral centre, leading to
significant obscurement of the Pake splitting; al-
though quite commonly intensity persists at frequen-
cies corresponding to those predicted for symmetric
w xmotions about the same axis 33,50–55 .
 .Eq. 1 dictates that a CD group on an immo-3
bilised peptide side chain should give rise to a single
Pake doublet of about 40 kHz splitting this presumes
rotational motion about the C–CD axis, which is3
.valid except at temperatures far below 08C . In the
present experiments it was considered that the inten-
sity advantage and favourable motional character-
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istics of the deuteromethyl groups could permit iden-
tification of up to four intense Pake doublets in the
spectra, and subsequent relation to overall peptide
behaviour in the membrane.
Typical spectra of EGFR , Neu , and Neu )tm tm tm
in POPC bilayers are displayed in Fig. 2. With some
samples precautions were taken to avoid cooling
below room temperature prior to spectroscopy; how-
ever, this was not seen to change the overall spectral
result. A sharp peak in the middle of each spectrum
could be separately resolved on an expanded fre-
 .quency axis into two components not shown here .
One of these, offset about 0.3 kHz downfield from
the powder spectrum midpoint, represents residual
deuterated water; the other, about which the powder
pattern is symmetric, reflects the presence of some
vesicles with high curvature for which the quadrupole
splittings are motionally averaged to zero. These
general features of 2H NMR powder spectra of am-
phiphiles in liposomes will not be further considered
here.
For EGFR at 6 mol% in bilayer membranes wetm
have demonstrated previously that the dominant spec-
tral features approximate a superposition of single
w xPake doublets from each CD group 41 . Thus the3
w xspectral feature contributed by d Ala was one4 623
w xPake doublet, while d Val gave a pair of dou-8 650
 .blets one for each valine methyl group , and
w xd Met produced a doublet with evidence of spec-3 644
tral asymmetry manifest as an additional central peak.
The positions of these four doublets are indicated by
arrows in Fig. 2 at 658C the quadrupole splittings are
 4  44.7 kHz Ala , 2.6 kHz Met , 1.1 and 4.7 kHz
 4.Val . Where non-methyl deuterons existed these
produced only minor features due to their low rela-
tive numbers and to relaxation effects see also Ref.
w x.56 . Spectral widths were less than 40 kHz, yet
spectra were essentially Pake doublet in nature at
physiological temperatures; hence, it is clear that
deuterated EGFR undergoes rapid axial rotation intm
these membranes.
 .Spectra for Neu and Neu ) in POPC Fig. 2tm tm
were similar in overall width to those obtained for
EGFR , but with most of the intensity present as atm
‘pyramidal’ shape suggesting axial asymmetry of
probe motion. This was true even in highly fluid
Fig. 2. 2H NMR spectra corresponding to EGFR , Neu and Neu ) in POPC bilayers. Each peptide contained three deuterated aminotm tm tm
acids as described in Fig. 1. Spectra are shown for peptiderphospholipid mol ratios of 6:100 and 1:100. The number of accumulated
transients represented by each spectrum is 400,000, 500,000 and 300,000 for EGFR , Neu and Neu ), respectively. Spectra havetm tm tm
been normalised within each column, without allowing for possible intensity loss based on peptide immobilisation at low temperatures.
w xArrows in the upper left spectrum indicate peak locations for the four deuteromethyl groups in EGFR as assigned previously 41 .tm
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membranes—i.e., 65–758C, and with dilution of the
peptide down to 1 mol% relative to phospholipid. A
 .very narrow central doublet 0.2 kHz splitting with
relatively low intensity also existed. Spectra of Neutm
and Neu ) displayed poorly-defined shoulders totaltm
.width 3–6 kHz in the most fluid membranes. In the
case of Neu ) these tended to disappear with tem-tm
perature reduction. Spectra corresponding to Neu )tm
at 6 mol% were generally wider than those of compa-
rable Neu samples.tm
We noted previously with regard to EGFR thattm
as sample temperature was decreased the Pake-doub-
let spectral shape could become progressively ob-
scured by a shift of intensity from the 908 spectral
edges toward the spectral centre - presumably due to
increased peptide–peptide association and increas-
w xingly asymmetric motion 41 . In membranes contain-
ing cholesterol the effect was dramatic. Fig. 3 illus-
trates typical spectral features observed after addition
of 33 mol% cholesterol to the membranes of samples
such as those described in Fig. 2: the temperature-
and-cholesterol-related effects on EGFR can betm
seen in comparing the left hand columns of Figs. 2
and 3. Gradual appearance of broad spectral peaks at
q20 kHz and y20 kHz i.e., quadrupole splitting
.DV s40 kHz in the spectra of cholesterol-contain-Q
ing samples is associated with peptide that has been
slowed to the point that it is not undergoing rotational
motions of frequency greater than about 104 sy1.
These phenomena seen for EGFR were reflected intm
the experimental results for Neu , but were particu-tm
larly notable in the case of Neu ). Thus whentm
temperature was reduced for membranes containing
Neu ) spectral shoulders at about q3 kHz and y3tm
kHz tended to become obscured, especially in the
presence of cholesterol. Obvious outer spectral peaks
appeared at q20 kHz and y20 kHz which increased
in intensity at lower temperature. These peaks corre-
Fig. 3. 2H NMR spectra corresponding to EGFR , Neu and Neu ) in POPCrcholesterol bilayers. Each peptide contained threetm tm tm
deuterated amino acids as described in Fig. 1. Spectra are shown for peptiderphospholipid mol ratios of 6:100 and 1:100. The number of
accumulated transients represented by each spectrum is 400,000 to 600,000. Vertically expanded regions are shown as inserts to permit
more accurate comparison of low intensity outer spectral features. Spectra have been normalised within each column, without allowing
for possible intensity loss based on peptide immobilisation at low temperatures. Arrows in the upper left spectrum indicate peak locations
w xfor the four deuteromethyl groups in EGFR as assigned previously 41 .tm
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.sponding to 40 kHz splitting were relatively reduced
in intensity in membranes having low peptide con-
centration, whereupon spectra of Neu ) becametm
similar to those of Neu .tm
A variety of alternative approaches to sample
preparation were tested in an effort to ensure that the
generally asymmetric nature of the peptide motion
suggested by spectra of Neu and Neu ) was not atm tm
function of sample preparation technique. Selected
results of such experiments are presented in Fig. 4.
w xThe rapid dilution method used by Killian et al. 57
to incorporate a variety of hydrophobic peptides into
bilayer membranes was tested by dissolving Neu intm
TFE and adding the solution to an aqueous suspen-
sion of POPC which was then further diluted with
 .water Fig. 4A . Replacement of TFE with hexa-
fluoroisopropanol HFI—a particularly good solvent
.for hydrophobic peptides for solubilising lipid and
peptide prior to drying and subsequent hydration
 .produced identical spectra Fig. 4B . This was also
true when formic acidracetic acidrCHCl rethanol3
 .  .1:1:2:1 was substituted for TFE spectra not shown .
Detergent dialysis with subsequent collection on su-
crose density gradients—an approach used by Smith
w xet al. 21 in dealing with similar peptides—did not
 .alter the result spectra not shown . Addition of the
negative-charged phospholipid, phosphatidylserine
 .PS , and sonication produced similar spectra: e.g.,
PS, was added to POPCrcholesterol bilayers contain-
ing 1 mol% Neu producing a final lipid ratio oftm
.1:7:3.5 PSrPOPCrcholesterol ; the sample was vor-
texed and then probe sonicated to the point of signifi-
cant suspension clearing; and spectra were run before
and after freeze–thawing the latter to ensure a larger
.  .liposome population Fig. 4D . Assembly of Neutm
into fluid bilayers of the 14-carbon-fatty-acid host
matrix, DMPC, produced the result shown in Fig. 4C.
Fig. 4 also includes spectra of Neu deuteratedtm
2 Fig. 4. H NMR spectra corresponding to peptides deuterated only in alanine residues EGFR at Ala and Neu at Ala —left handtm 623 tm 661
.and middle columns, respectively , and for selected Neu samples with deuteration at Ala , Leu and Val but prepared bytm 661 667 676
 .alternative routes right hand column . Spectra are shown for peptiderphospholipid mol ratios of 6:100 and 1:100. Right hand column:
 . w x  .A dilution method of Killian et al. 57 ; B hexafluoroisopropanol substituted for TFE in the preparation method described in Section 2;
 .  .C DMPC substituted for POPC in the preparation method described in Section 2; D phosphatidylserine added to a 1 mol% Neutm
sample as described in Section 3 to give a mol ratio of 7:3.5:1 POPCrcholesterolrPS. Spectra have been normalised within each column.
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selectively at Ala for comparison with EGFR661 tm
deuterated selectively at Ala middle and left hand623
.columns, respectively . Once again the Neu spectratm
suggest axially asymmetric motion. CD spectra of
Neu in the TFE solvent generally employed for thetm
present work demonstrated features very similar to
those for EGFR and characteristic of predomi-tm
 .nantly a-helical array spectra not shown .
Fig. 5 presents freeze-fracture electron micro-
graphs of the typical structures found in the samples
Fig. 5. Freeze-fracture electron micrographs of typical NMR samples. In the top row samples contained 6 mol% peptide in POPC alone:
 .  .  .  .  .A EGFR , B Neu , C Neu ). In the middle row samples contained 6 mol% peptide in POPCrcholesterol: D EGFR , Etm tm tm tm
 .  .  .Neu , F Neu ). The effect of reduction in peptide concentration to 1 mol% is shown in the bottom row: G EGFR in POPC, Htm tm tm
 .Neu ) in POPC, and I Neu ) in POPCrcholesterol. Arrows point from ice to liposome edge. Bar indicates 200 nm. Shadowtm tm
direction is from bottom to top of page.
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used for 2H NMR spectroscopy. In this technique a
rapidly-frozen specimen is fractured in vacuum at
y1108C and the fracture face is immediately shad-
owed with an atomic layer of platinum and carbon.
The fracture plane is known to split bilayer mem-
branes between their component monolayers. The
hydrophobic membrane interior exposed by the frac-
ture plane shows the presence of particulate disconti-
 .nuities ‘bumps’ . Such peptide-related features in
bilayer model membranes are thought to be closely
analogous to the ‘intramembranous particles’ that
w xcharacterise fracture faces of cell membranes 58 and
model membranes containing transmembrane pro-
w x teins 59 . The particle size distribution measured on
the basis that a single ‘particle’ is a bump without
visible internal fine structure—i.e., which cannot be
.further subdivided visually ranged from 4.6 to 6.9
nm in the absence of cholesterol, and from 4.6 to 9.2
nm in the cholesterol-containing membranes. The
particles seen in liposomes without cholesterol Fig.
.5A,B,C appeared less sharply resolved than those in
 .membranes with cholesterol Fig. 5D,E,F , and tended
to be less clustered. Note too that obvious IMPs were
 .strikingly disproportionately reduced in number in
POPC membranes when the peptide concentration
 .was reduced to 1 mol% Fig. 5G,H ; while this was
less the case in membranes containing cholesterol
 .Fig. 5I . Under comparable conditions the appear-
ance of the fractured samples was essentially indistin-
guishable amongst the three peptides studied.
4. Discussion
We have previously reported wideline 2H NMR
spectra of EGFR in lipid bilayers, with emphasistm
w xon characterisation of deuteration sites 41,42 . In the
present work, we attempted a comparison of overall
motional behaviour amongst membrane-associated
portions of EGFR and two other Class I RTKs. Intm
each case the peptide studied comprised the putative
transmembrane domain plus an additional 10–11
 .amino acids extending into the C-terminal cytoplas-
mic domain. Relevant levels of comparison include:
EGFR to Neu , 6% peptide to 1% peptide, POPCtm tm
host matrix to POPCrcholesterol, and normal pheno-
 .  .type Neu to transformed phenotype Neu ) .tm tm
Based on past experience, the primary sample prepa-
ration technique used was hydration of thin films
dried down from peptiderlipid solutions made in the
 .solvent, trifluoroethanol TFE . TFE is a ‘lipo-
mimetic’ solvent known to support a-helical arrange-
ment in peptide segments for which this secondary
w x w xstructure is the native form 60–63 . Killian et al. 57
have cautioned that hydrophobic peptide aggregation
can occur after prolonged incubation in TFE and
.HFI , however we have not observed that spectra of
samples prepared in this manner are influenced by
sample history; and we can produce the same 1 mol%
peptide spectrum by making a fresh sample or by
redissolving and ‘diluting with lipid’ a previous 6
w xmol% sample. Bouchard et al. 64 concluded that
 .organic solvent choice ethanol vs. TFE influenced
the initial dimer type for gramicidin in DMPC bilay-
ers, although within hours the ethanol form adopted
the more natural form produced using TFE. In the
present work, we screened a very wide variety of
sample preparation techniques for Neu peptides, and
observed no important effect on our results.
The Neu peptides gave spectra indicative of signif-
icantly axially asymmetric motion in all samples
studied; whereas for EGFR such spectra were asso-tm
ciated with the presence of cholesterol, reduced tem-
w xperature, and higher peptide concentrations 42 .
Spectra reflecting axially asymmetric motion are in
general not seen for deuterated hydrophobic peptides
that have been previously reported in fluid bilayer
membranes at such low peptiderlipid ratios e.g.,
w x.41,65–70 . However they are common for deuter-
ated molecules whose rotational rates are slowed to
the range 103–104 sy1 or less in gel phase mem-
branes: in such cases spectral intensity typically shifts
from a Pake doublet powder pattern into a more
centrally-peaked pattern i.e., like the Neu peptide
.spectra as the motion becomes more asymmetric.
The membranes examined in the present work were
all fluid, and most spectra were narrower than the 40
kHz value expected for immobilised peptide CD3
groups. For a-helical peptides in fluid bilayer mem-
branes a major axis of motional averaging is the
membrane perpendicular. These results for the Neu
peptides might well be anticipated for molecules
whose axial diffusion is interfered with by inter-
molecular associations that lead to asymmetric rota-
tion about the membrane perpendicular andror to
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slowed rotation about this axis. 2H NMR spectra
which are apparently highly analogous to those seen
here for Neu peptides and to EGFR spectra seen attm
low temperature in cholesterol-containing mem-
. w xbranes have been observed by Mueller et al. 66 for
a hydrophobic dipeptide subjected to a major reduc-
tion in membrane fluidity. Very similar spectra have
w xalso been described by MacDonald and Seelig 67 in
 .association with peptide–peptide gramicidin inter-
actions brought about by raised peptide concentra-
w xtion. Lee et al. 71 have suggested that slow grami-
cidin axial diffusion in fluid membranes can arise
from intermolecular interactions.
It might be presumed that elevated temperatures
and highly fluid membranes would tend to reduce
inter-peptide associations, leading to maximal peptide
dispersion in the membrane and resultant axially
symmetric motion. Certainly reducing peptide con-
centration in the membrane can be expected to reduce
peptide–peptide association. However even at 65–
758C and 1 mol% in POPC, spectra of Neu re-tm
mained characteristic of significantly axially asym-
metric motion. As mentioned above, the fact that
Neu spectral widths were much less than the 40tm
kHz anticipated for highly immobilised CD groups3
indicates that the labelled species is in fact undergo-
ing axial diffusion within the membrane at rates
greater than 104 sy1. Thus, our working hypothesis is
that, for peptides corresponding to the NeurerbB-2
transmembrane domain, dimer-roligomerisation is a
high probability event-leading to asymmetric rotation
within the membrane. Ideally, one could test this by
further reduction of the peptide concentration, but the
NMR technique used is not sensitive enough to detect
significantly smaller sample quantities with present
equipment. The existence of a difference between
EGFR and Neu with regard to self-associationtm tm
affinity is consistent with the concept that transmem-
brane sequence can determine RTK self-association
w x16,17 .
Spectra of Neu ) were wider than correspondingtm
spectra of Neu in membranes containing 6 mol%tm
peptide. Moreover, incorporation of cholesterol into
the membrane led to the appearance of considerable
spectral intensity at q20 kHz and y20 kHz for
Neu ) i.e., spectral splitting some 40 kHz—indi-tm
.cative of strong peptide immobilisation . The immo-
bilising effect of cholesterol was much less obvious
in spectra of Neu . In the absence of cholesterol,tm
reduction in peptide concentration within the limits
 .possible 6 to 1 mol% had little effect on spectra of
Neu or Neu ); however, in membranes contain-tm tm
ing cholesterol, reduction in peptide concentration
from 6 to 1 mol% dramatically narrowed spectra of
Neu )—i.e., reversed the cholesterol-induced pep-tm
tide immobilisation. These observations may be seen
as indicative of a greater tendency to extensive
oligomerisation in the case of Neu ).tm
Sternberg and Gullick have developed a structural
basis as to how NeurerbB-2 monomers might associ-
w xate within the membrane 18,19,72 and references
.therein . They suggest that a motif of some five
amino acids is involved in homodimerisation of a
number of monomeric receptors, and that the trans-
membrane domain is intrinsically a-helical. They
have applied this logic in particular to the Val “664
Glu oncogenic transformation which underlies the
present Neu rNeu ) comparison. Their sugges-tm tm
tion has been that, based on a greater tendency of the
transmembrane domain of the transformant to self-as-
sociate, signalling is constitutively activated by the
Val “Glu substitution. Such a concept is very664
exciting as a possible molecular basis for loss of
w xgrowth control. Smith et al. 21 have favoured a
related model for NeurerbB-2, and have demon-
strated consistent behaviour of transmembrane pep-
tides by optical spectroscopy and magic angle spin-
ning NMR. Another important model for the Neu
transformant studied in the present work is that, in
order to dimerize, the transmembrane domain must
be fully a-helical and that this represents a higher
energy state for the native species than for the trans-
w xformant 17,20 and references therein; see also Ref.
w x.73 .
In the modelling studies mentioned above, the
homodimer of the transmembrane domain is typically
 .seen as a right handed pair crossing at a significant
w x w xangle 10 . MacKenzie et al. 74 demonstrated via
high resolution NMR spectroscopy that this is the
case for the transmembrane a-helical domains of the
glycophorin A dimer in detergent solution crossing
 4 .angle y 408 , and that stabilisation is by van der
w xWaals forces. Smith et al. 21 have performed opti-
cal spectroscopy and magic angle spinning NMR
studies on a transmembrane peptide from Neu incor-
porated into bilayer membranes, finding evidence of
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a crossing angle of about 508 and of measurably
different orientation for the analogous peptide from
the Val “Glu transformant. Our results offer some664
 .support for such concepts. In principal, Eq. 1 per-
mits absolute correlation of spectral splittings with
orientation of the C–D bond; although this presumes
knowledge of the S term. Assuming that the pep-mol
tides studied here take on a helical secondary struc-
ture, then existing literature observations suggest that
S for the overall helix would be in the range of 0.9mol
w x w x.38,69 , see also Ref. 21 . The CD group of3
alanine can be expected to be rigidly affixed to this.
We have previously pointed out with regard to mod-
elling of EGFR that for a standard right handedtm
a-helix the C–CD bond of the deuterated alanine3
 .should be directed near the magic angle 54.78 with
w xrespect to the helix long axis 41 . Thus, the spectral
quadrupole splitting for the methyl deuterons should
approach zero if the helix axis is perpendicular to the
membrane bilayer. In fact the spectral width observed
for this alanine in EGFR and Neu is some 6–10tm tm
 .kHz Fig. 4 —i.e., up to 25% of the theoretical
maximum of 40 kHz. While this is hardly compelling
evidence of a given peptide orientation, it is certainly
consistent with expectations that the angle between
the peptide long axis and the membrane perpendicu-
lar is considerably removed from 08. Moreover, in
our hands there are basic differences in behaviour
between Neu and Neu )—particularly in mem-tm tm
branes containing cholesterol. It is interesting that the
transformant peptide demonstrated evidence of greater
tendency to form large oligomers greater apparent
.immobilisation , and that the spectral difference was
reduced at low peptide concentration—consistent
with the concept that interactions of higher order than
dimerisation may occur in signalling pathways. Our
results cannot however be seen as evidence for greater
 .dimerisation as opposed to oligomerisation of
 .Neu ) vs. Neu although this may be the casetm tm
since all spectra of both Neu peptides were measur-
ably asymmetric.
Freeze-fracture electron microscopy of the NMR
samples demonstrated the liposomal nature of the
material studied, and that the same features existed
for all three peptides. It is important to note that this
 .technique i utilizes atomic shadowing to produce a
 .PtrC replica some 2 nm thick, and ii relies upon
rapid freezing that can induce lateral rearrangement
of receptors over at least 10–20 nm in the model
w xmembrane 59 . It is generally considered that in
freeze-fracture electron micrographs of cell mem-
branes IMPs represent the locations of one or more
w xtransmembrane proteins 58 . Given that in our exper-
iments there is one peptide per 15–16 phospholipids
at 6 mol% peptide, the density of obvious particles in
the membrane fracture faces is less than that which
would be expected if each represented a monomeric
peptide. The possibility that the IMPs seen represent
peptide oligomers in reversible equilibrium with ‘in-
.visible’ monomers or dimers is further born out by
the freeze-fracture appearance of the 1 mol% sam-
ples: reduction in peptide concentration led to a
disproportionate reduction in the particle density in
membranes with cholesterol and to virtually complete
disappearance in the membranes of POPC without
 .cholesterol Fig. 5 . Such results are highly consistent
w xwith the conclusions of Segrest et al. 75 surrounding
a proteolytic fragment containing the transmembrane
domain of glycophorin in lipid bilayers: this peptide
gave rise to freeze-fracture IMPs of the size de-
scribed in the present work, and the peptides ap-
 w x.peared to represent oligomers see also Ref. 59 . It
seems reasonable to conclude that the similarity in
freeze-fracture appearance amongst EGFR , Neu ,tm tm
and Neu ), in the face of their very different 2Htm
NMR behaviour, indicates that the spectral differ-
ences recorded reflect processes occurring on a
smaller scale than the resolution limit of freeze-frac-
ture EM.
w xKillian et al. 57 have described a series of experi-
ments highlighting the important topic of mismatch
in hydrophobic length between transmembrane pep-
w xtide and membrane 76 . The concept exists that a
peptide might be induced to cluster as a result of such
mismatch: this might at first sight be considered the
source of differences in behaviour between EGFRtm
and Neu in the present work. Presuming a righttm
handed a-helix of 3.6 residues per turn, the calcu-
lated length of the 23-residue putative hydrophobic
˚ w xdomain displayed for EGFR is 34.5 A 77 . Thistm
compares with a calculated hydrophobic membrane
˚ thickness for POPC bilayers of 25.8 A at 258 vs.
˚29.9 A for the same membranes containing 30 mol%
. w xcholesterol 78 . The relevant peptide hydrophobic
 .dimension perpendicular to the plane of the bilayer
˚would be reduced to 31.3 A if the EGFR a-helixtm
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were oriented at 258 to the bilayer normal for in-
stance if dimers were formed having a crossing angle
.of y508 . One might conclude therefore that EGFRtm
is slightly ‘too long’ for the membrane, that greater
w xhydrophobic mismatch 57,76,79,80 occurs in the
case of membranes without cholesterol, and that this
mismatch will increase at higher temperatures. For
Neu , which has only 21 residues in the putativetm
transmembrane region calculated via the Rost ap-
w xproach 49 , the relevant length of the hydrophobic
˚ ˚stretch is 31.5 A 28.5 A at a 258 angle to the bilayer
.normal . It seems that in the system described in the
present work the Neu peptides represent if anything a
closer match to the membrane thickness than does
EGFR , and thus that hydrophobic length mismatchtm
may not be a driving force for the spectral differences
seen here. DMPC hydrophobic thickness of fluid
˚ w x.bilayers 22.8 A 57 provides some potential for
testing this conclusion in that the ratio of Neutm
hydrophobic domain to DMPC hydrophobic thick-
ness is 1.38, while the comparable ratio for EGFRtm
to POPC is 1.34: i.e., the hydrophobicity mismatch of
Neu in fluid DMPC might be seen as the same astm
that of EGFR in POPC. Spectra of Neu in DMPCtm tm
remained intrinsically typical of axially asymmetric
 . motion Fig. 4 C although there may be some
evidence of more clearly identifiable shoulders than
. w xin POPC . We have noted previously 41 that
EGFR in fluid DMPC gave rise to Pake spectratm
qualitatively similar to those found in POPC.
5. Conclusions
In fluid phospholipid membranes at physiological
temperatures there is a measurable tendency for the
isolated transmembrane domain of the EGF receptor
to form homodimers or oligomers. This tendency is
significantly increased in the presence of cholesterol,
although peptide–peptide association remains re-
versible and is most marked at low temperatures. The
transmembrane domain of another Class I receptor
tyrosine kinase, NeurerbB-2, appears to have a
greater tendency to homodimerr-oligomer formation
in fluid membranes. There are very significant intrin-
sic differences in the motional behaviour of the mem-
brane-spanning peptides from these two Class I RTKs
at the peptiderlipid ratios studied. The transmem-
brane domain of the oncogenic NeurerbB-2 mutant
in which there is a Val “Glu substitution has a664
greater tendency toward formation of large oligomers
than does the corresponding peptide from the normal
phenotype.
We suggest that, in general, transmembrane a-
helices such as those studied here will tend to re-
versibly associate with one another in bilayer mem-
branes due to relatively poor fit into the surrounding
liquid crystal host matrix. For fluid membranes, we
expect this to be particularly true in the presence of
 w x.cholesterol see also Ref. 81 . The affinity of pep-
tide–peptide association in such a context should be
influenced by amino acid sequence via its determina-
 .tion of how closely and with what orientation s the
peptides can pack to optimize inter- or intra-peptide
bonding while minimising disruption of lipid–lipid
interactions. For full-length RTKs this process will be
further affected by the bulky portions extending be-
yond the membrane surface.
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